White Paper: Marketing Drugs and Medical Devices through Social Media – 5 Ways to Ensure Compliance

  • By: ComplianceOnline
  • Date: July 10, 2014
Webinar All Access Pass Subscription Abstract:

The explosion in use of social media over the past few years has been both a blessing and a curse for life sciences companies and consumers who use their products. While platforms such as Facebook and Twitter might present a great opportunity for marketing products, the limitations of the tools can present regulatory pitfalls for companies and dangers to consumers. The rapid pace of technological progress has caught agencies such as the FDA and FTC on the wrong foot and they have struggled to formulate and implement regulations on social media use. It is clear though that the onus for compliance lies with regulated companies. However, the overlap between regulations for conventional marketing and promotion and social media guidelines that are still evolving has led to confusion about compliance requirements. This white paper discusses 5 ways in which drug and device companies can stay on the right side of the regulatory agencies and ensure that they don’t attract penalties for violations.

Bookmark and Share
Best Sellers
You Recently Viewed